AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Allison M Johnson

Examiner Allison M Johnson appears to be about average relative to their peer examiners. Their lifetime grant ratio is 17.1%, they average 1.75 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU Very Hard
Difficulty vs Group About Average
Difficulty vs TC About Average
Difficulty vs USPTO About Average
Average OA / Grant 1.75
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
3 years (2024-2026)
Phone
(703) 756-1396
Predicted Supervisor
Tracy Vivlemore
Supervisor Phone
(571) 272-2914
Tech Center
1600 - Biotechnology and Organic
Group
1630 - Stem Cells and Nucleic Acid Related Therapy

Metrics

Applications Evaluated
70
Granted Applications
12
Non-Granted Applications
58
Avg OA / Grant
1.75
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1638
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 17.1% 1.75
Art Unit 15 37.6% 1.45
Group 243 38.4% 2.18
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2024; examiner may not yet have been active in the available dataset.
2024 13 6 46.2%
2025 44 6 13.6%
2026 13 0 0.0%

12 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 68 2.9% 25.0% 50.0% 8.8%
2 48 0.0% 10.4% 66.7% 16.7%
3 22 0.0% 13.6% 81.8% 4.5%
4 5 0.0% 0.0% 80.0% 20.0%
5 2 0.0% 0.0% 50.0% 50.0%
6 1 0.0% 0.0% 0.0% 100.0%
7 1 0.0% 0.0% 100.0% 0.0%
8 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2023
3.5%
2024
0.0%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.